SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-19-010671
Filing Date
2019-06-07
Accepted
2019-06-07 16:15:42
Documents
2
Period of Report
2019-06-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3460
2 EXHIBIT 24 ex24.htm EX-24 8668
  Complete submission text file 0001140361-19-010671.txt   13599
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Issuer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address NOVEN PHARMACEUTICALS, INC. 11960 SW 144TH STREET MIAMI FL 33186
Business Address
Brandt Peter C. (Reporting) CIK: 0001434099 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34079 | Film No.: 19885907